1. Home
  2. DGLY vs CYCC Comparison

DGLY vs CYCC Comparison

Compare DGLY & CYCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DGLY
  • CYCC
  • Stock Information
  • Founded
  • DGLY 2004
  • CYCC 1992
  • Country
  • DGLY United States
  • CYCC United States
  • Employees
  • DGLY N/A
  • CYCC 12
  • Industry
  • DGLY Radio And Television Broadcasting And Communications Equipment
  • CYCC Biotechnology: Pharmaceutical Preparations
  • Sector
  • DGLY Technology
  • CYCC Health Care
  • Exchange
  • DGLY Nasdaq
  • CYCC Nasdaq
  • Market Cap
  • DGLY 2.4M
  • CYCC 2.2M
  • IPO Year
  • DGLY N/A
  • CYCC N/A
  • Fundamental
  • Price
  • DGLY $0.43
  • CYCC $0.36
  • Analyst Decision
  • DGLY
  • CYCC Strong Buy
  • Analyst Count
  • DGLY 0
  • CYCC 1
  • Target Price
  • DGLY N/A
  • CYCC $11.00
  • AVG Volume (30 Days)
  • DGLY 548.3K
  • CYCC 6.4M
  • Earning Date
  • DGLY 12-30-2024
  • CYCC 11-12-2024
  • Dividend Yield
  • DGLY N/A
  • CYCC N/A
  • EPS Growth
  • DGLY N/A
  • CYCC N/A
  • EPS
  • DGLY N/A
  • CYCC N/A
  • Revenue
  • DGLY $21,131,122.00
  • CYCC $74,000.00
  • Revenue This Year
  • DGLY $22.14
  • CYCC N/A
  • Revenue Next Year
  • DGLY N/A
  • CYCC $88.68
  • P/E Ratio
  • DGLY N/A
  • CYCC N/A
  • Revenue Growth
  • DGLY N/A
  • CYCC N/A
  • 52 Week Low
  • DGLY $0.38
  • CYCC $0.31
  • 52 Week High
  • DGLY $3.29
  • CYCC $4.00
  • Technical
  • Relative Strength Index (RSI)
  • DGLY 36.60
  • CYCC 43.22
  • Support Level
  • DGLY $0.43
  • CYCC $0.34
  • Resistance Level
  • DGLY $0.66
  • CYCC $0.39
  • Average True Range (ATR)
  • DGLY 0.06
  • CYCC 0.08
  • MACD
  • DGLY 0.00
  • CYCC 0.00
  • Stochastic Oscillator
  • DGLY 18.32
  • CYCC 6.30

About DGLY Digital Ally Inc.

Digital Ally Inc produces digital video imaging and storage products for use in law enforcement, security, and commercial applications. Its products are an in-car digital video/audio recorder contained in a rear-view mirror for use in law enforcement and commercial fleets. It can integrate electronic, radio, computer, and multi-media technologies to create solutions to address needs in a variety of other industries and markets, including mass transit, school buses, taxicab, and military. The company sells its products directly to law enforcement agencies, security organizations, and consumer and commercial fleet operators both domestically and internationally through third-party distributors. Its segments include Video Solutions, Revenue Cycle Management, and Entertainment.

About CYCC Cyclacel Pharmaceuticals Inc.

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.

Share on Social Networks: